In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Recent findings, reported on November 15, 2025, have cast a shadow over one of the most anticipated breakthroughs in ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

A team of researchers at the Federal University of ABC (UFABC) in Brazil has developed a new chemical compound with the ...

Nearly 7 million Americans currently live with Alzheimer’s and by 2060, experts say that number could be as high as 14 ...

Scientists tested the substance on rats with positive results and are now seeking partnerships with pharmaceutical companies to conduct clinical trials. A research team at the Federal University of AB ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

Kinney Drugs is partnering with the Alzheimer's Association to present a free webinar. Attendees will learn the ten early ...

"Going after a few diseases, where Alzheimer's is number one by quite a bit, the imperative is very, very clear," Gates added ...

Bill Gates shares personal insights on Alzheimer’s and a new FDA-approved blood test that could revolutionize early diagnosis ...